The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
Krutova M, Capek V, Nycova E, Vojackova S, Balejova M, Geigerova L, Tejkalova R, Havlinova L, Vagnerova I, Cermak P, Ryskova L, Jezek P, Zamazalova D, Vesela D, Kucharova A, Nemcova D, Curdova M, Nyc O, Drevinek P.
Krutova M, et al. Among authors: nyc o.
Antimicrob Resist Infect Control. 2020 Jun 30;9(1):98. doi: 10.1186/s13756-020-00765-y.
Antimicrob Resist Infect Control. 2020.
PMID: 32605598
Free PMC article.